New isoform-specific monoclonal antibodies reveal different sub-cellular localisations for talin1 and talin2  by Praekelt, Uta et al.
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Talins  are  adaptor  proteins  that  connect  the  integrin  family  of  cell  adhesion  receptors  to  cytoskeletal  actin.
Vertebrates  express  two  closely  related  talins  encoded  by  separate  genes,  and  while  it is  well  established
that  talin1  plays  a  key  role  in cell  adhesion  and  spreading,  little  is  known  about  the  role  of  talin2.  To
facilitate  such  studies,  we  report  the characterisation  of 4 new  isoform-speciﬁc  talin  mouse  monoclonal
antibodies  that  work  in  Western  blotting,  immuno-precipitation,  immuno-ﬂuorescence  and  immuno-
histochemistry.  Using  these  antibodies,  we show  that  talin1  and  talin2  do  not  form  heterodimers,  and
that  they are  differentially  localised  within  the  cell.  Talin1  was  concentrated  in  peripheral  focal  adhesions
while  talin2  was  observed  in both  focal  and  ﬁbrillar  adhesions,  and  knock-down  of  talin2  compro-
mised  ﬁbronectin  ﬁbrillogenesis.  Although  differentiated  human  macrophages  express  both  isoforms,
only  talin1  showed  discrete  staining  and  was  localised  to the  ring  structure  of podosomes.  However,
siRNA-mediated  knock-down  of  macrophage  talin2  led to a signiﬁcant  reduction  in podosomal  matrixodosomes
onoclonal antibody
degradation.  We  have  also  used  the antibodies  to localise  each  isoform  in  tissue  sections  using both
cryostat  and parafﬁn-embedded  material.  In  skeletal  muscle  talin2  was  localised  to  both  myotendinous
junctions  and  costameres  while  talin1  was  restricted  to  the  former  structure.  In  contrast,  both  isoforms
co-localised  in  kidney  with  staining  of  the  glomerulus,  and  the  tubular  epithelial  and  interstitial  cells
of  the  cortex  and  medulla.  We  anticipate  that  these  antibodies  will form  a  valuable  resource  for  future
f  the  tstudies  on the  function  o
ntroduction
Cell adhesion to the extracellular matrix (ECM) plays a key role
n the migration, proliferation and differentiation of animal cells,
nd their organisation into tissues and organs during embryonic
evelopment. Several types of cell–ECM junctions have been char-
cterised in cultured cells (Dubash et al., 2009) including focal
omplexes formed at the leading edge of migratory cells, which in
urn mature into larger more elongated focal adhesions (FA). Fib-
illar adhesions (FB) are found in the central area of the cell and are
ssociated with the ﬁbronectin ﬁbrillogenesis (Cukierman et al.,
∗ Corresponding author. Tel.: +44 0116 223 1544; fax: +44 0116 229 7018.
E-mail address: drc@le.ac.uk (D.R. Critchley).
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2001), while podosomes and invadopodia are more specialised
adhesion structures that are only found in certain cell types (Block
et al., 2008). All the above cell–ECM junctions share the same gen-
eral architecture and composition, i.e. the extracellular domains
of the integrin family of / hetero-dimeric trans-membrane pro-
teins are bound to ECM proteins, while the short cytoplasmic tails
of the integrin -subunits are linked to the actin cytoskeleton
via a variety of adaptor proteins (Brakebusch and Fassler, 2003;
Legate and Fassler, 2009). One such adaptor is talin (∼270 kDa,
∼2540 amino acids) which binds both -integrin tails and F-actin
(Critchley, 2009), and also modulates the afﬁnity of integrin for lig-
ands (Anthis and Campbell, 2011; Shattil et al., 2010). Talin consists
Open access under CC BY license.of an N-terminal head containing an atypical FERM domain (Elliott
et al., 2010; Goult et al., 2010) that binds -integrin tails (Anthis
et al., 2009; Calderwood et al., 1999; Wegener et al., 2007) cou-
pled to an elongated ﬂexible rod with a second integrin binding
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ite (Gingras et al., 2009; Moes et al., 2007), at least two actin bind-
ng sites (Gingras et al., 2008; Hemmings et al., 1996), and multiple
inding sites for the cytoskeletal protein vinculin (Gingras et al.,
005). Much of talin in the cell is thought to exist in an autoinhib-
ted cytoplasmic form due to intramolecular interactions between
he head and rod (Goksoy et al., 2008; Goult et al., 2009), and both
ap1/RIAM (Han et al., 2006; Lee et al., 2009) and PIP2 (Goksoy et al.,
008; Martel et al., 2001) have been implicated in talin activation.
In vertebrates there are two talin genes, Tln1 and Tln2, which
ncode very similar proteins (74% amino acid sequence identity)
Debrand et al., 2009; Monkley et al., 2001). Tln2 appears to be the
ncestral gene with Tln1 arising by gene duplication early in the
hordate lineage (Senetar and McCann, 2005). However, the role of
he two major talin isoforms remains unclear. Knockout of Tln1 is
mbryonic lethal at gastrulation (Monkley et al., 2000) while Tln2
nockout mice are viable and fertile (Chen and Lo, 2005), although
hey have a mildly dystrophic phenotype that is more severe than
hat arising from muscle-speciﬁc knockout of Tln1 (Conti et al.,
008, 2009). Interestingly, talin2 has a much higher afﬁnity for the
ytoplasmic tail of 1D-integrin (Anthis et al., 2010), a splice vari-
nt that is localised with talin2 in the myotendinous junction of
triated muscle. This suggests a model in which the tight binding
f talin2 to 1D-integrin is designed to withstand the high forces
xerted on the myotendinous junction in vivo. Loss of both talin1
nd talin2 from muscle leads to severe defects in myogenesis and is
erinatal lethal, indicating that the two isoforms have overlapping
ut non-redundant functions in muscle (Conti et al., 2009).
Further progress in understanding the function of talin1 and
alin2 has been restricted by the lack of antibodies that are spe-
iﬁc for each isoform. Many of the commonly used commercial
ntibodies, e.g. 8d4 and TD77 (Sigma) recognise both isoforms,
hile the only talin1-speciﬁc antibody (TA205) detects human but
ot mouse talin1 (Bolton et al., 1997). Here we characterise four
ew isoform-speciﬁc monoclonal antibodies (Mabs) that detect
ither talin1 or talin2 from a range of species, and that work
n Western blotting, immuno-precipitation, immuno-ﬂuorescence
nd immuno-histochemistry. We  have used these antibodies to
nalyse the sub-cellular localisation and tissue distribution of both
soforms, and show for the ﬁrst time that in NIH3T3 cells, smooth
uscle cells, mouse embryo ﬁbroblasts and macrophages, the sub-
ellular localisation of these two very similar proteins is quite
istinct.
aterials and methods
thical statement
All procedures on animals were approved by one of the fol-
owing: (i) The Institutional Animal Care and Use Committee of
anderbilt University according to the NIH Guide for the Care and
se of Laboratory Animals – protocol number M/04/219 from Van-
erbilt Medical Center. (ii) The University College London local
nimal ethical committee review following guidelines set out by
he 1986 UK Home Ofﬁce Animal Procedures Act under the Home
fﬁce Licence PPL 70/7086.
onoclonal antibody generation
The recombinant talin immunogens were puriﬁed his-tagged
olypeptides containing residues 489–911 of mouse talin1 and
he corresponding region of mouse talin2 (residues 492–914), and
esidues 2300 to the C-terminus of mouse talin1 and the corre-
ponding region of mouse talin2. Antibodies to talin1 and talin2
mmunogens were raised in BALB/C mice at Harlan Laboratories,
K. Test bleeds were analysed by ELISA and Western blottingCell Biology 91 (2012) 180– 191 181
against recombinant proteins. Spleen cells were fused with NS0
cells, and hybridomas selected following screening by ELISA against
recombinant protein. Positive hybridoma supernatants were
immediately tested in Western blots against recombinant talin1
and talin2 polypeptides to check speciﬁcity, and selected hybrido-
mas  were sub-cloned twice The talin1- and talin2-speciﬁc anti-
bodies described in this study are available from Cancer Research
Technology (http://www.cancertechnology.com/tools/antibodies).
Western blotting
Cells or tissues were lysed in Laemmli sample buffer (62.5 mM
Tris–HCl pH 6.8, 20% glycerol, 2% SDS, 5%  mercaptoethanol),
and extracted proteins were resolved by SDS-PAGE and blotted
to PVDF membranes. Antibodies were used as follows: afﬁn-
ity puriﬁed 97H6, 68E7 and 121A used at 0.1 g/ml and 93E12
hybridoma supernatant diluted 1/50. Other antibodies used were:
anti-vinculin F9 (Santa Cruz), HRP-coupled anti-mouse and anti-
rabbit were from GE Healthcare.
Cell culture and transfection
NIH3T3 mouse ﬁbroblasts, rat aortic smooth muscle cells and
mouse embryo ﬁbroblasts were grown in DMEM with 10% foetal
calf serum at 37% in 10% CO2 and cultured on uncoated plastic
dishes (VWR). Sub-conﬂuent cells were trypsinised, washed in PBS
and replated at a density of 4 × 104 cells on uncoated glass cover-
slips in 24-well plates (Raymond A. Lamb). Cells were ﬁxed after
2, 4, 6 or 24 h. Human primary macrophages were isolated from
peripheral blood with a Ficoll gradient. The cells were left to adhere
and cultivated for 7 days on plastic dishes in RPMI1640 with 20%
human serum.
Mouse talin1 cDNAs and human talin2 cDNA were ampli-
ﬁed by PCR, cloned into pEGFP-N1 (Clontech) and the constructs
validated by sequencing. All DNA used for transfection exper-
iments was puriﬁed using the Endofree MidiPrep Kit (Qiagen).
Sub-conﬂuent NIH3T3 cells were trypsinised, washed in PBS, and
electroporated (6 × 106 cells/ml) using a Microporator (Invitrogen)
according to the manufacturer’s instructions with 0.5 g of plasmid
DNA encoding GFP or GFP-talin1 or GFP-talin2 and/or 100 pmol
of a Dharmacon ON-TARGET plus SMARTpool E-065877-00-0005
against mouse talin2.
siRNA-induced talin2 knock-down in human macrophages
Human talin2-speciﬁc siRNAs were obtained from Thermo
Scientiﬁc Dharmacon: siGENOME siRNA, Human TLN-2-03:
5′-GAUGUGCGAUCACCACUAU-3′ and Human TLN-2-02 5′-
GGACGACCCUUCCAUGUAC-3′; control ﬁreﬂy luciferase siRNA#2
(Thermo Scientiﬁc) was used as negative control. Cells were
transiently transfected using a MicroPorator MP-100 (PeqLab,
Erlangen, Germany) combined with the 100 l tips from NEON
transfection system (Invitrogen, Darmstadt, Germany) using the
following speciﬁcations: pulse voltage 1000 V, pulse width 40 ms,
pulse number 2. Cells (1 × 105) were seeded on coverslips, and
72 h later, either ﬁxed and stained or whole cell lysates prepared
for Western blotting.
Matrix degradation assay
Porcine gelatin (Roth, Karlsruhe, Germany) was ﬂuorescently
labelled using NHS-rhodamine (Thermo Scientiﬁc, Rockford, IL)
according to Chen et al. (1994).  Coverslips were coated with
labelled matrix solution, ﬁxed in 0.5% glutaraldehyde (Roth,
Karlsruhe, Germany) and washed with 70% ethanol and medium.
Cells were seeded at a density of 8 × 104 on coated coverslips, and
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xed with 3.7% formaldehyde/PBS after 6 h. Quantiﬁcation of NHS-
hodamine gelatin ﬂuorescence intensities was performed using
mageJ software. For comparability, laser intensity was not changed
etween measurements. For each value, 3 × 20 cells were eval-
ated. Statistical analysis was performed with Graphpad Prism
oftware. Differences between mean values were analysed using
he Student’s t-test.
mmuno-ﬂuorescence microscopy on cells in culture
Cells grown on glass coverslips were ﬁxed and permeabilised in
ce-cold methanol for exactly 1 min, and cells were then blocked
ith 2.5% normal goat serum and 2.5% normal mouse serum
or 15 min  before staining for F-actin with Alexa 647-phalloidin
1:200), anti-ﬁbronectin (Sigma, 1:200) or HM5.1 anti-5 integrin
1:50; Santa Cruz) in 1% BSA in PBS + 2.4 mM EGTA, 2.4 mM MgCl2.
alin1 and talin2 were detected with Mabs 97H6 and 68E7 diluted
:20 if supernatants were used, or 5 g/ml if puriﬁed antibodies
ere used. Alexa-488 or Alexa-594 coupled secondary antibodies
Molecular Probes) were used at a dilution 1:200. Confocal laser
canning microscopy was conducted using either a Leica TCS SP5
ystem consisting of a Leica DMI-6000 CS inverted microscope or an
lympus FV1000 system with an inverted IX81 motorised micro-
cope.
For quantiﬁcation of talin1 or talin2 positive structures, epiﬂu-
rescence microscopy images were analysed using ImageJ (NIH).
fter conversion to 8-bit images, the outlining tool was  used to
etermine cell area, and a threshold of 20–250 pixels (equiva-
ent to = 0.2–25 m2) was set to measure the number and size
f talin-positive adhesion complexes. This threshold was deter-
ined empirically beforehand to exclude signals derived from
iffuse cytoplasmic staining for talin. For each experiment, 30 cells
ere analysed and the experiment was conducted in triplicate.
 two-tailed unpaired Student’s t-test was performed to test for
igniﬁcance.
mmuno-staining of skeletal muscle cryosections
C57BL/6 or talin2-null mice were sacriﬁced, gastrocnemius
uscles collected, immersed in OCT and snap-frozen in liquid
itrogen-cooled isopentane. For immunohistochemistry, 12 m-
hick sections were ﬁxed in methanol at −20 ◦C for 5 min, incubated
ith 10% goat serum/PBS for 30 min  and incubated with MOM
it Blocking Reagent (Vector Labs, CA) for 1 h. Sections were then
ashed three times in PBS, incubated with antibodies to talin1
97H6) and talin2 (68E7) at 5 g/ml for 1 h, followed by incuba-
ion with Alexa Fluor 594 for 1 h. Nuclei were counterstained with
oechst 33342 (Invitrogen). Images were acquired with a Leica
M4000B microscope and processed using Metamorph and ImageJ
oftware.
mmuno-staining of formalin-ﬁxed parafﬁn embedded sections of
idney
Mouse kidneys were perfused through a transcardial aortic can-
ula with 3.7% formaldehyde, 10 mM sodium m-periodate, 40 mM
hosphate buffer and 1% acetic acid (which quenches endoge-
ous biotin), then dehydrated and parafﬁn-embedded (Zhang et al.,
010). Sections were de-parafﬁnised, soaked in 100% ethanol, and
hen incubated for 20 min  in 100% methanol containing 0.3% H2O2
o quench endogenous peroxidase activity. The sections were rehy-
rated, blocked with PBS containing 10% normal goat serum for 1 h
t room temperature and then incubated with either isotype con-
rol or primary antibody diluted in PBS containing 1% normal goat
erum overnight at 4 ◦C. Afﬁnity puriﬁed 97H6, 68E7, and 121A
ere used at a concentration of 2 g/ml, and 93E12 was  used at aCell Biology 91 (2012) 180– 191
dilution of 1:10. Primary antibodies were localised using Vectastain
ABC Elite (Vector, Burlingame, CA) with diaminobenzidine (DAB) as
chromogen, followed by a light counterstain with toluidine (Zhang
et al., 2010).
Immuno-precipitation
NIH3T3 cell lysates (700 g total protein) were incubated with
3 g primary antibody (97H6, 68E7, 121A) or IgG control and
rotated overnight at 4 ◦C. The following day, the solution was  incu-
bated with 50 l protein G agarose beads (Roche) with rotation at
4 ◦C for 1 h. Beads were washed three times with lysis buffer (10 mM
Tris–HCl, pH 8, 100 mM NaCl, 1% NP-40, 2 mM sodium orthovana-
date, protease inhibitor cocktail (Roche)) and resuspended in 50 l
2× Laemmli sample buffer. Samples were analysed by Western
blotting using the appropriate antibodies (afﬁnity puriﬁed 97H6
and 68E7, Vinculin (Sigma clone hVIN-1)), 1 integrin (BD Trans-
duction clone 18/CD29).
Results
Monoclonal antibodies (Mabs) recognising either the N- or the
C-terminal regions of the talin1 or talin2 rod domain (Fig. 1A) were
generated by immunising mice with recombinant talin polypep-
tides as described in the “Materials and methods” section. Two
Mabs (93E12 and 97H6) were identiﬁed that recognised the
talin1 but not talin2 immunogen in Western blots (Fig. 1B). Both
were immunoglobulin type IgG1 (Fig. S1A), and using overlapping
polypeptides, we  showed that they recognised different epitopes
(Fig. 1C). 97H6 recognised residues 482–655, a 5-helix bundle at
the start of the talin1 rod (Papagrigoriou et al., 2004) while 93E12
recognised residues 655–911 (Fig. 1A and C). We  also generated
Mab  68E7, a talin2-speciﬁc Mab  against the N-terminal region
of the talin2 rod (Fig. 1B), and epitope mapping showed that it
recognised residues 489–655 (data not shown). A commonly used
commercial talin Mab  8d4 also recognises the N-terminal region
of talin1 in Westerns (Fig. 1B), but it also detected the equivalent
region of talin2, albeit to a lesser degree. A second talin2-speciﬁc
Mab, 121A, was  obtained from immunisations with a C-terminal
talin2 polypeptide (Fig. 1A and B). The epitope was mapped by
peptide display using the E. coli protein EspA (Crepin et al., 2005)
to the 14 amino acids (KAAFGKADDDDVVV) spanning residues
2476–2494 (data not shown). Both talin2-speciﬁc antibodies were
of the IgG2b isotype (Fig. S1A).
In order to conﬁrm the ability of these antibodies to detect full-
length talins, we  tested them against lysate from cells expressing
either GFP-talin1, GFP-talin2 or GFP alone by Western blot-
ting (Fig. 1D). Both 97H6 and 93E12 detected only GFP-talin1
(or the endogenous talin1 in untransfected cells), but not GFP-
talin2. Similarly the talin2 Mabs 68E7 (Fig. 1D) and 121A (not
shown) recognised only GFP-talin2 plus the endogenous talin2 in
untransfected cells. The commercial Mab  8D4 detected primarily
GFP-talin1 (Fig. 1D) although upon longer exposure it also detected
GFP-talin2 (not shown). The speciﬁcity of the talin1 antibodies
was  further demonstrated using mouse embryo ﬁbroblasts derived
from mice carrying conditional Tln1 and Cre/ER alleles. Activation
of Cre recombinase with 4-hydroxy tamoxifen (4-OHT) inactivates
the Tln1 gene and resulted in near complete loss of the talin1 signal
as detected using the 97H6 Mab  (Fig. 1E). Because the Tln2 gene is
far more complex, it has not been possible to use a similar approach
to generate Tln2 null cells (Debrand et al., 2009). We  have there-
fore deleted the entire coding region of the Tln2 gene (Debrand
et al., in preparation), and Western blots of Tln2(−/−) embryos show
a complete loss of talin2 protein as detected using the 68E7 Mab
(Fig. 1F).
U. Praekelt et al. / European Journal of Cell Biology 91 (2012) 180– 191 183
Fig. 1. Characterisation of isoform-speciﬁc talin monoclonal antibodies. (A) Domain structure of talin. The N-terminal talin head, which is comprised of an atypical FERM
domain,  is linked to the talin rod by an unstructured region (zig-zag) containing a calpain-II cleavage site. The talin rod contains 61 -helices (grey ovals) organised into a
series  of amphipathic -helical bundles, and terminates in a single helix responsible for talin dimerisation. Boxes indicate established domain boundaries. The location of the
recombinant polypeptides used to generate Mabs and the position of their epitopes is shown either above (talin1) or below (talin2) the diagram. (B) Puriﬁed recombinant
talin  rod polypeptides (50 ng) spanning residues 489–911 (upper panel) or 2300–2542 (lower panel) were resolved by SDS-PAGE and either stained with Coomassie blue
(coo)  or analysed by Western blotting using talin Mabs 97H6, 93E12, 68E7, 121A as well as the commercial talin Mab  8d4 (Sigma). (C) The epitopes recognised by Mab
93E12  and 97H6 were further deﬁned using recombinant talin1 rod polypeptides containing either residues 482–655 or residues 656–911. Mab  97H6 recognises the former
while  93E12 recognises the latter. (D) Western blots of whole cell lysates from untransfected mouse embryo ﬁbroblasts (40 g protein) or lysates from cells expressing
either  GFP-talin1, GFP-talin2 or GFP alone (2.5 g protein) probed with the talin Mabs indicated. (E) Mouse embryo ﬁbroblasts homozygous for a conditional Tln1 allele
and  carrying a tamoxifen-inducible Cre recombinase were treated with 100 nM 4-hydoxy tamoxifen (4-OHT) dissolved in ethanol (+) or ethanol alone (−). After 72 h, cells
were  replated, and after a further 24 h analysed for talin1 expression by Western blotting using the 97H6 Mab. Vinculin was used as a loading control. (F) Heterozygous Tln2
knockout mice (+/−) were crossed, and 12.5dpc (+/−)  or (−/−) embryos analysed for expression of talin1 (97H6 Mab) or talin2 (68E7 Mab) by Western blotting. (G) Lysates
from  NIH3T3 were immunoprecipitated with either a control IgG, the talin1-speciﬁc Mab  97H6 or the talin2-speciﬁc Mabs 68E7 and 121A, and the immunoprecipitates and
whole  cell lysate (WCL) analysed by Western blotting using the talin1-speciﬁc Mab  97H6, the talin2-speciﬁc Mab  68E7, the 1-integrin Mab  (BD Transduction) and a vinculin
Mab  (Sigma). (H) Tissue lysates (TL) from mouse kidney were immunoprecipitated with either a control IgG, the talin2-speciﬁc Mab  68E7 or the talin1-speciﬁc, Mab  97H6
and  immunoprecipitates analysed by Western blotting using the talin2-speciﬁc Mab  121A. The ∼90 kDa protein detected by Mab  121A in kidney TL is a C-terminal talin2
polypeptide spanning residues 1608–2543 (Debrand et al., 2009) which is not recognised by the 68E7 Mab.
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The talin1 97H6 Mab  and the two talin2 Mabs 68E7 and
21A were also able to speciﬁcally immuno-precipitate their
espective antigens from NIH3T3 cells along with the talin-
inding partners 1-integrin and vinculin (Fig. 1G). Interestingly,
mmuno-precipitation of talin1 with Mab  97H6 did not lead to
oimmuno-precipitation of talin2 either from NIH3T3 cells (Fig. 1G)
r mouse tissues lysates (Fig. 1H). Similarly, immuno-precipitation
f talin2 with Mabs 68E7 or 121A did not lead to co-immuno-
recipitation of talin1 demonstrating for the ﬁrst time that the two
soforms do not form heterodimers.
se of isoform-speciﬁc antibodies to study the sub-cellular
ocalisation of talin1 and talin2
To establish whether the isoform-speciﬁc Mabs were suitable
or sub-cellular localisation studies, we initially used NIH3T3 cells,
hich express both talin isoforms. Both the talin1-speciﬁc 97H6
nd the talin2-speciﬁc 68E7 Mabs worked most effectively on
ethanol-ﬁxed cells rather than paraformaldehyde/TritonX100 or
ormaldehyde/acetone-treated cells (data not shown). Interest-
ngly, while talin1 was primarily localised in FA found at the cell
eriphery, talin2 was found in both FA and elongated structures
hroughout the body of the cell (Fig. 2A) suggesting that the two
soforms have different functions. We  therefore compared the
ocalisation of talin1 and talin2 in several other cell types using
sotype-speciﬁc secondary antibodies to identify both talin1 and
alin2 in the same cell. The picture that emerges is essentially the
ame as in NIH3T3 cells, and is illustrated here with images from rat
ortic smooth muscle cells and mouse embryo ﬁbroblasts (Fig. 2B).
hus, talin1 was  localised to FA whereas talin2 was  found in both
A and structures in the centre of the cell that aligned in the same
irection as actin stress ﬁbres (not shown), and resemble ﬁbrillar
dhesions (FB).
When NIH3T3 cells were stained at different times after replat-
ng, talin2 was initially found in a large number of small dot-
nd rod-shaped structures spread evenly across the cell (Fig. 2C).
ver time, these structures appeared to fuse, and their number
ecreased while their size increased (Fig. 2C and D). In contrast,
he talin1-positive FA changed very little in number or size over this
eriod (Fig. 2C and D). Thus, the two talin isoforms show both differ-
nt dynamics as well as sub-cellular localisations in NIH3T3 cells,
ith talin1-positive FA forming within the ﬁrst hour after replating,
hile formation and maturation of the talin2-containing structures
ccurred over a much longer time frame. To establish if the talin2
ontaining structures were FB, NIH3T3 cells were co-stained with
ntibodies to ﬁbronectin (Fig. 3A) and 5-integrin (Fig S1B). This
howed that there was substantial co-localisation between talin2,
bronectin and 5-integrin particularly in the centre of the cell.
alin1 localisation on the other hand was quite distinct from that
or ﬁbronectin (Fig. 3A).
The localisation of talin2 predominantly to FB prompted us to
xplore its possible role in ﬁbronectin ﬁbrillogenesis, and we  there-
ore performed talin2 siRNA knock-down experiments in NIH3T3
ells. Transfection of cells with a talin2 Dharmacon siRNA SMART
ool led to a substantial reduction in talin2 levels as judged by
mmunoﬂuorescence (Fig. 3B) and Western blotting (Fig. 3C) at
he 72 h time-point, further demonstrating the speciﬁcity of the
alin2 antibodies. However, talin1 expression was unaffected (data
ot shown), and there appeared to be no change in FA or stress
bre formation (Fig. 3E), or in cell spreading (Fig. 3B) compared to
ells transfected with the control siRNA. In contrast, the number
f cells with ﬁbronectin ﬁbrils was reduced 72 h post-transfection
rom 75% to 40% (Fig. 3B and D). Instead, ﬁbronectin staining was
ocalised around the nucleus (Fig. 3B). Importantly, re-expression of
FP-tagged human talin2 in cells depleted of mouse talin2 restored
B formation (Fig. 3F and G). In summary, the results demonstrateCell Biology 91 (2012) 180– 191
that talin1 and talin2 localise to different structures in three dif-
ferent cell types, and that in NIH3T3 cells, talin2 is required for
efﬁcient ﬁbronectin ﬁbrillogenesis.
Talin1 but not talin2 is localised in podosomes
It has been reported that talin1 is the only talin isoform
expressed in cells of the haematopoetic lineage such as B cells,
platelets and dendritic cells (Lammermann et al., 2008; Manevich-
Mendelson et al., 2010; Nieswandt et al., 2007; Petrich et al.,
2007). However, our microarray data suggest that talin2 expres-
sion is upregulated as monocytes differentiate into macrophages
(S. Linder et al., unpublished data), and Western blotting using
the isoform-speciﬁc antibodies conﬁrmed that both talin1 and
talin2 are expressed in differentiated human peripheral blood
macrophages (Fig. 4A). It is also noteworthy that the antibodies
did not cross-react with any other macrophage proteins further
demonstrating their speciﬁcity.
One of the major adhesion structures in macrophages is the
podosome, which can be distinguished from other adhesion struc-
tures by its characteristic two-part architecture consisting of an
F-actin rich core surrounded by a ring structure containing many
of the proteins typically found in FA (Linder and Kopp, 2005). We
therefore stained differentiated macrophages with the isoform-
speciﬁc talin antibodies. Interestingly, we  found that while talin1
was  localised to the outer ring structure (Fig. 4B), talin2 was  not
present in podosomes, a ﬁnding conﬁrmed using the two differ-
ent talin2-speciﬁc Mabs (data not shown) that recognise different
regions of the protein (Fig. 1A). Indeed, we saw no speciﬁc talin2
staining in macrophages, and both the diffuse and the punctate
staining observed on the ventral surface in a few cells appeared to
be non-speciﬁc as it remained after siRNA talin2 knock-down.
To establish whether talin2 has any functional relevance in pri-
mary macrophages, we knocked talin2 protein levels down using
an siRNA approach. Western blotting conﬁrmed that cells treated
for 72 h with two  different talin2 speciﬁc siRNAs showed a speciﬁc
reduction of talin2, but not talin1 compared to cells treated with
the luciferase control siRNA (Fig. 4A). This result was conﬁrmed by
immunoﬂuorescence staining for talin1 which remained localised
in the podosome outer ring structure (Fig. 4B). Moreover, the num-
ber of podosomes per cell was unchanged in talin2 knock-down
cells (not shown). Talin2 knock-down and control cells were subse-
quently seeded on a ﬂuorescently labelled gelatin matrix, and after
6 h, the degree of matrix degradation was evaluated by ﬂuorescence
intensity measurements of the area covered by cells. For control
cells, the matrix-associated ﬂuorescence intensity was reduced to
30.01 ± 2.54%, while for talin2 knock-down cells, the value was only
reduced to 49.98 ± 1.66% (Fig. 4C). Importantly, the talin2 siRNAs
did not affect the levels of the matrix-metalloproteinases MT1-
MMP,  MMP2  and MMP9  (Fig. 4A). These ﬁndings indicate that
although depletion of talin2 has no apparent effect on the local-
isation of talin1 in podosomes, or on the number of podosomes per
cell, it does reduce the matrix-degrading capacity of macrophages
without affecting the expression of MT1-MMP, MMP2  and MMP9.
Tissue distribution of talin1 and talin2
Previous data indicates that talin1 and talin2 mRNAs are dif-
ferentially expressed in both mouse and human tissues (Debrand
et al., 2009; Monkley et al., 2001). To get an indication of the relative
protein abundance, we used the isoform-speciﬁc talin antibodies
to carry out Western blotting on a range of mouse tissues (Fig. 5A).
We found that talin1 appeared to be the predominant isoform in
spleen, liver and lung while talin2 was the predominant isoform in
brain and skeletal muscle. In heart and kidney, both appeared to be
expressed about equally. As Mab  121A is directed to the C-terminal
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Fig. 2. Sub-cellular localisation and dynamics of talin1 and talin2 in various cell types. NIH3T3 cells, smooth muscle cells (SMC) and mouse embryo ﬁbroblasts (MEF) were
grown  on glass coverslips. (A) Confocal microscopy images of cells stained separately with Mabs to either talin1 (97H6) or talin2 (68E7). (B) Confocal microscopy images of
cells  co-stained with both talin1 and talin2 Mabs (97H6 and 68E7) followed by isotype-speciﬁc secondary antibodies (talin1 97H6 IgG1, talin2 68E7 IgG2b). Talin1 (green);
Talin2  (red). (C) NIH3T3 cells stained for talin1 or talin2 either 2 h or 24 h after replating onto glass coverslips. Scale bars = 10 m. (D) Quantiﬁcation of number and size of
talin1  or talin2 positive structures from (C) 2, 4, 6 or 24 h after replating. All results are expressed as mean ± SEM where N = 30 per time point. P-values for number of talin1
versus  talin2 structures per cell: 2 h: 0.0006; 4 h: 0.0001; 6 h: 0.0005; 24 h: 0.089. Size of talin1 versus talin2 structures per cell: 2 h: 0.0001; 4 h: 0.0004; 6 h: 0.074; 24 h:
0.4;  *P values of < 0.05. Note: The size of talin2 positive FB at later time points is underestimated due to the “thresholding” method (see the “Materials and methods” section)
used  to exclude cytoplasmic staining of talin which overlaps talin2 staining in central FB. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of the article.)
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Fig. 3. Talin2 localises to ﬁbrillar adhesions and talin2 knock-down leads to a decrease in ﬁbronectin ﬁbrils. (A) Confocal microscopy of NIH3T3 cells cultured on glass coverslips
for  24 h and stained for talin1 (97H6; top row) or talin2 (68E7; bottom row) and ﬁbronectin. (B) NIH3T3 cells were transfected with 100 pmol of either a SMARTpool siRNA
against  mouse talin2 or a control siRNA, and 72 h post transfection were ﬁxed and stained for talin2 (68E7) and ﬁbronectin. (C) Cells transfected with the talin2 siRNA or
control  siRNA were analysed by Western blotting for talin2 (68E7) or vinculin 24, 48 and 72 h after transfection. (D) Percentage of cells with FB 48 h or 72 h after transfection
with  the talin2 siRNA or control siRNA. (E) NIH3T3 cells transfected with the talin2 siRNA and stained for either vinculin or F-actin (phalloidin) 72 h after transfection. (F)
Confocal images of NIH3T3 cells transfected with either human GFP-talin2 or GFP together with the mouse talin2 siRNA, followed 72 h later by staining for ﬁbronectin. (G)
Quantitation of FB in NIH3T3 cells 72 h after transfection with human GFP-talin2 or GFP along with the mouse talin2 siRNA. Error bars are ±SEM. N = 30. Scale bars = 10 m.
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Fig. 4. Knock-down of talin2 leads to a reduction of podosomal matrix degradation in primary human macrophages. (A) Western blots of macrophage lysates 72 h after
transfection with the talin2 siRNAs indicated. Blots were probed for; left – talin2 (Mab 121A1), middle – talin1 (Mab 97H6), right – -actin loading control and the matrix
metalloproteinases (MMP)  indicated. MMP2  and MMP9  rabbit polyclonal antibodies were obtained from Santa Cruz and the anti MT1-MMP  antibody was from Millipore. (B)
Primary  human macrophages transfected with a control luciferase siRNA (upper panels) or a talin2 siRNA (lower panels) for 72 h, were seeded on coverslips, stained for talin1
(green)  or F-actin (blue) and imaged by confocal laser scanning microscopy. Note localisation of talin1 to podosome rings surrounding F-actin-rich cores. (C) Knockdown of
talin2  reduces podosome-dependent gelatin matrix degradation. Human macrophages transfected with a talin2 siRNA or control luciferase siRNA for 72 h were seeded on a
rhodamine-labelled gelatin matrix for 6 h, and then ﬁxed and stained for F-actin (blue). Dark areas indicate the region of matrix degradation. The degree of gelatin matrix
degradation was  quantiﬁed (±SD) by measuring the primary ﬂuorescence under each of 20 cells using confocal laser scanning microscopy. The experiments were conducted
in  triplicate. The ﬂuorescence intensity of the undegraded labelled matrix was set at 100%. Asterisks indicate a P value < 0.0001. Magniﬁcation bar = 10 m. (For interpretation
of  the references to colour in this ﬁgure legend, the reader is referred to the web version of the article.)
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Fig. 5. Expression of talin1 and talin2 in various mouse tissues and their immuno-localisation in muscle and kidney. (A) Western blot of whole tissue lysates (40 g
protein) probed with the talin1- or talin2-speciﬁc antibodies shown. Tissues: B, brain; H, heart; S, spleen; K, kidney; Lu, lung; Li, liver; M,  skeletal muscle. (B) Cryo-sections
of  gastrocnemius muscle were immunostained with Mab  97H6 directed against talin1 (a and b) and Mab  68E7 against talin2 (c–f). Talin1 was  mostly localised to the
myotendinous junction (MTJ) (arrows in a), with weaker staining of costameres (b), while talin2 staining was  strong at both MTJ (arrows in c) and costameres (d). In talin2-
null  muscle, no staining was  detected at the MTJ  (arrows in e) or at costameres (f). Scale bar = 50 m.  (C) Immuno-staining of parafﬁn-embedded sections of wild type and
talin2  null mouse kidney with antibodies to talin1 (93E12 and 97H6) and talin2 (68E7 and 121A). Staining is present in the glomerulus, tubules and interstitium in the cortex,
and  the tubules and interstitium in the medulla. There was no staining for talin2 in kidneys from Tln2-null mice.
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egion of talin2, it detects both full-length (270 kDa) talin2 and the
hort 90 kDa kidney isoform that is expressed from an internal pro-
oter (Debrand et al., 2009). The commercial antibody 8D4 gave
n expression proﬁle more like that of talin1 consistent with the
onclusion that it has a higher afﬁnity for talin1.
To establish whether these antibodies were able to detect the
wo major talin isoforms in tissues, we initially stained cryostat
ections of skeletal muscle where talin2 is the predominant iso-
orm (Fig. 5A). In agreement with previous studies using rabbit
olyclonal antibodies (Conti et al., 2009), talin2 showed strong
taining in both the myotendinous junctions and costameres of
ouse gastrocnemius muscle (Fig. 5B c–e), and importantly, there
as no staining for talin2 in muscle from talin2 knockout mice
Fig. 5B e and f). In contrast, talin1 staining was mostly localised
o the myotendinous junction with very little staining apparent in
ostameres (Fig. 5B a and b). Given the relative low abundance of
alin1 in muscle, the lack of costamere staining could be a sensitivity
ssue. Nevertheless, the results clearly show that talin1 in muscle
s predominantly localised at the myotendinous junction.
We also sought to establish whether the antibodies worked on
arafﬁn-embedded formalin ﬁxed tissue by staining sections of
idney which contains substantial amounts of both talin isoforms
Fig. 5A). Sections stained positively for both talin1 (Mabs 93E12
nd 97H6) and talin2 (Mabs 68E7 and 121A), and each showed
imilar staining patterns (Fig. 5C). Staining was present in the
lomerulus and also in tubular epithelial and interstitial cells of
oth the cortex and the medulla. No staining was  observed in kid-
ey sections stained with the appropriate isotype controls (data not
hown), and no staining was observed in talin2 null kidneys using
ither the 68E7 or 121A Mabs (Fig. 5C).
iscussion
Here, we describe four new Mabs speciﬁc for talin1 or talin2 that
re suitable for Western blotting, immuno-precipitation, immuno-
uorescence and immuno-histochemistry on both cryo-sections
nd formalin-ﬁxed parafﬁn-embedded material. The isoform speci-
city of the antibodies was conﬁrmed by Western blotting
f cells expressing GFP-tagged recombinant talins, conditional
alin1 knockout cells and talin2 knockout embryos, by immuno-
recipitation and by the loss of talin2 staining in muscle and kidney
ections from knockout mice. We  have also previously shown that
alin1 staining is lost in frozen sections of developing embryoid
odies from talin1(−/−) ES cells, while talin2 staining was  unaf-
ected (Liu et al., 2011). While other isoform-speciﬁc antibodies for
alin2 have been described (Senetar et al., 2007), these are the only
abs reported that recognise mouse talins and that are suitable for
 wide range of uses.
Using these antibodies, we report for the ﬁrst time clear dif-
erences in the sub-cellular localisation, dynamics and functions
f the two talins. In ﬁbroblasts, talin1 was principally localised
n FA while talin2 was in both FA and FB, and was required for
bronectin matrix assembly. Talin1 and talin2 also showed differ-
ntial localisation within muscle whereas in kidney, they showed
o-localisation. Unlike other cells of the haemopoetic lineage, dif-
erentiated macrophages expressed both talin isoforms although
nly talin1 was localised in podosomes. However, talin2 knock-
own signiﬁcantly reduced the ability of macrophages to degrade
atrix pointing to a podosome-related function of talin2.
Previous studies suggest that Tln2 is the ancestral gene (Senetar
nd McCann, 2005). It is a large gene (>400 kb) due to the large
ize of the introns, encodes several splice variants and contains
 number of promoters (Debrand et al., 2009). Indeed, testis and
idney express much smaller variants of talin2 as a result of
lternate promoter usage. Tln1 on the other hand evolved moreCell Biology 91 (2012) 180– 191 189
recently, and is a much smaller gene (∼30 kb) with a less com-
plex gene structure, although the boundaries of the coding exons
are totally conserved. Both genes are widely expressed, although
Western blotting shows that the relative level of the major isoforms
varies substantially between tissues. Whereas most cells appear to
express both isoforms, cells of haemopoetic origin and endothe-
lial cells only express talin1, and talin2 is not upregulated when
talin1 is depleted from endothelial cells (Kopp et al., 2010). The
talin2 promoter lies within a CpG island (Debrand et al., 2009) and
in haemopoetic cells may  be silenced by methylation.
Little is known about the biochemical differences between the
two  major talin isoforms. Talin1 is a dimer, and dimerisation is
mediated by the C-terminal helix (Gingras et al., 2008) which has a
very similar sequence in talin2, raising the possibility that the two
isoforms might form heterodimers. However, using the isoform-
speciﬁc antibodies, we show that immuno-precipitation of talin1
from NIH3T3 cells and mouse tissues does not bring down talin2
and vice versa, indicating that talins exist as homodimers. This is
entirely consistent with immuno-localisation studies which show
that the two isoforms are differentially distributed within the same
cell. Talins binds to -integrin cytoplasmic tails via their N-terminal
FERM domains (Anthis et al., 2009, 2010) although there is also an
integrin binding site in the talin rod (Gingras et al., 2009; Moes
et al., 2007). Interestingly, the talin2 FERM domain has a slightly
higher afﬁnity for -integrin tails than the talin1 FERM domain,
and in particular, it binds to the muscle-speciﬁc 1D-integrin
splice variant far more tightly than any other known interaction
between -integrin subunits and talin. Both a structural (Anthis
et al., 2009) and thermodynamic (Anthis et al., 2010) explanation
for this observation has recently been reported, and the tight bind-
ing is consistent with the localisation of 1D-integrin and talin2
to the MTJ  where they are thought to be important in withstand-
ing the forces exerted on the MTJ  during muscle contraction (Conti
et al., 2008, 2009).
Otherwise, there is no data on novel binding partners that might
account for the different localisation of talin1 and talin2 in other cell
types. The ﬁnding that talin1 rapidly localises to FA whereas recruit-
ment of talin2 to FB is signiﬁcantly slower suggests that they have
distinct functions and also modes of regulation. Talin1 is negatively
regulated by a head/rod interaction that masks the integrin binding
site in the FERM domain (Goksoy et al., 2008; Goult et al., 2009),
and PKC signalling, Rap1 and its effector RIAM have all been shown
to be important in talin1 and hence integrin activation (Han et al.,
2006; Lee et al., 2009). Whether this same pathway is involved in
regulating talin2 has not been explored. However, despite differ-
ences in their dynamics, endogenous talin2 compensates for loss
of talin1 in ﬁbroblasts (Zhang et al., 2008), and the effects of talin1
knock-down in endothelial cells (which only express talin1) can
be rescued by transfection of a talin2 cDNA (Kopp et al., 2010). In
contrast, talin2 appears unable to compensate for loss of talin1 in
early embryonic development (Monkley et al., 2000, 2011). More-
over, although talin1 and talin2 co-localise in embryoid bodies at
the epithelial/basement membrane junction, talin1-null embryoid
bodies are defective in integrin adhesion complex assembly and
signalling, and elongation of the embryonic epithelium, despite the
continued presence of talin2 (Liu et al., 2011). The underlying cause
appears to be increased proteasomal destruction of epithelial 1
integrin in the absence of talin1. We  show here that talin1 and
talin2 also co-localise in kidney tubular epithelial cells, and it will
be interesting to explore their relative roles in kidney development
and function.
The talin2-positive elongated adhesions in the centre of the cell
reported here appear to be FBs since the talin2 staining is coin-
cident with that for ﬁbronectin and 5-integrin. Interestingly, in
the ﬁrst publication on talin (Burridge and Connell, 1983), the
authors noted talin staining associated with ﬁbres in the cell centre
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artially co-localising with ﬁbronectin, but they assigned the stain-
ng to stress ﬁbres instead of FB which had yet to be described.
he authors also reported talin staining as having a “doughnut-
haped appearance with a non-ﬂuorescent core surrounded by a
uorescent ring”. Presumably these were podosomes or invado-
omes. More recently, talin2 staining has been described as “long
dhesions in the midbody of the cell” (Senetar et al., 2007). Here,
e show that talin2 knock-down in NIH3T3 cells compromised FB
ut not FA assembly, and the cells mislocalised ﬁbronectin despite
he continued expression of talin1. This and the fact that the talin2
nock-down phenotype was rescued by expressing a human talin2
DNA strongly suggests a unique role for talin2 in FB formation
nd ﬁbronectin ﬁbrillogenesis. The current model of FB formation
nvisages that 5-integrins and the adaptor protein tensin translo-
ate out of FA along actin stress ﬁbres in a process that involves ILK
Stanchi et al., 2009), Src-mediated tyrosine phosphorylation and
yosin II activity (Zamir and Geiger, 2001). Our recent studies show
hat it is the tensin3 isoform that is enriched in FB while tensin2 is
nriched in FA (Clark et al., 2010). However, knock-down of tensin3
id not block ﬁbronectin matrix assembly in human ﬁbroblasts
nlike the effects of talin2 knock-down in NIH3T3 cells reported
ere. Early on in cell spreading, we observed a multitude of talin2-
ositive dot and rod shaped structures in the centre of the cell that
ppeared to fuse over time into larger ﬁbrillar structures that par-
ially co-localised with ﬁbronectin. This suggests that talin2 (but
ot talin1) may  play a role in activating 51 integrin in the cen-
re of the cell, coupling it to the actomyosin contractile apparatus
hich is essential for both FB and ﬁbronectin matrix assembly.
The ﬁnding that talin1, but not talin2, is localised in podosomes
as unexpected. Talin1 localised to the outer ring of the podosome
hich contains integrins and associated proteins typical of FA, as
ell as regulatory proteins such as PI3K, Src, Pyk2/FAK (Linder
nd Aepfelbacher, 2003). However, it is puzzling that we were
nable to detect any speciﬁc staining for talin2 in differentiated
acrophages under the conditions tested. Nevertheless, the fact
icroarray data indicate that talin2 may  be upregulated during
onocyte to macrophage differentiation (S. Linder, unpublished
ata) suggests an important role of talin2 in macrophage physiol-
gy. Indeed, matrix degradation assays showed that knock-down
f talin2 signiﬁcantly impaired the matrix degrading ability of pri-
ary human macrophages without affecting expression of matrix
etalloproteinases, and it will be interesting to establish whether
acrophages isolated from talin2 knockout mice are functionally
mpaired. Germline deletion of the talin2 gene does not result in any
bvious phenotype and the mice are viable and fertile (Chen and Lo,
005; Debrand et al., 2009), although maintaining a colony of mice
n which the complete Tln2 gene has been deleted is challenging
or reasons that are not yet understood (Debrand et al., unpub-
ished data). Again, it will be interesting to investigate whether
acrophage-dependent responses to pathogens are impaired in
ln2 null mice. In conclusion, it is clear that talin1 and talin2 have
istinct functions at least in some cell types, and the availability
f the isoform-speciﬁc antibodies reported here provide a valuable
ool for future studies.
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